Amcon Distributing Co
DIT NYSE Wholesale-Groceries, General Line Financials FY2016βFY2025
What Amcon Distributing Co does
No business description yet.
- Legal name
- AMCON DISTRIBUTING CO
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K Β· Nov 7, 2025
- Accession Β· CIK
- 0001104659-25-108504
0000928465
Revenue and margins
Amcon Distributing Co had $2.8B of revenue in fiscal 2025, up 3.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β21.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $9.7M in fiscal 2025, 0.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amcon Distributing Co returned $1.8M to shareholders in fiscal 2025, 18% of free cash flow. The diluted share count rose 1.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Amcon Distributing Co can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $0.5M | $0.4M | $0.8M | $0.7M | $0.7M |
| Debt incl. finance leases | $5.6M | $9.0M | $13.6M | $21.8M | $16.5M |
| Net debt / EBITDA | 0.2x | 0.3x | 0.4x | 0.8x | 0.7x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.2x | 0.1x |
| Interest coverage | 13.3x | 10.0x | 3.0x | 1.7x | 1.2x |
| Current ratio | 2.9x | 2.9x | 3.2x | 2.5x | 2.1x |
| Quick ratio | 0.9x | 1.1x | 1.1x | 0.9x | 0.8x |
| Total assets | $188M | $289M | $363M | $374M | $391M |
| Total liabilities | $111M | $196M | $259M | $262M | $278M |
| Shareholders' equity | $77.6M | $92.8M | $104M | $112M | $113M |
| Net debt (β = net cash) | $5.1M | $8.5M | $12.8M | $21.1M | $15.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 9 | 6 / 9 | 5 / 9 | 6 / 9 | 6 / 9 | 5 / 9 | 6 / 9 | 5 / 9 | 4 / 9 |
| Accruals ratio | β11.2% | 13.8% | β1.7% | 9.8% | β5.6% | β2.9% | β2.6% | β2.5% | β17.2% | β4.7% |
| Altman Z'' | 7.41 | 6.87 | 6.50 | 6.60 | 5.40 | 5.93 | 5.27 | 4.89 | 4.10 | 3.68 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.3B | $1.3B | $1.3B | $1.4B | $1.5B | $1.7B | $2.0B | $2.5B | $2.7B | $2.8B |
| Gross profit | $74.8M | $72.4M | $76.9M | $84.0M | $87.7M | $101M | $128M | $171M | $182M | $188M |
| Operating income | $10.9M | $6.2M | $5.9M | $6.3M | $9.1M | $17.8M | $22.6M | $26.0M | $18.0M | $12.6M |
| Interest expense | $0.7M | $0.8M | $1.2M | $1.6M | $1.7M | $1.3M | $2.2M | $8.6M | $10.4M | $10.4M |
| Pretax income | $10.3M | $5.4M | $4.8M | $4.8M | $7.5M | $16.7M | $21.5M | $17.3M | $7.5M | $1.6M |
| Income tax | $4.3M | $2.5M | $1.2M | $1.6M | $2.1M | $4.5M | $6.5M | $5.7M | $3.1M | $1.0M |
| Net income | $6.0M | $2.9M | $3.6M | $3.2M | $5.5M | $15.5M | $16.7M | $11.6M | $4.3M | $0.6M |
| Net income to common | $5.8M | $2.9M | $3.6M | $3.2M | $5.5M | $15.5M | $16.7M | $11.6M | $4.3M | $0.6M |
| Diluted EPS | $8.38 | $4.26 | $5.38 | $5.25 | $9.76 | $27.36 | $28.59 | $19.46 | $7.15 | $0.92 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $18.4M | β$13.8M | $5.9M | β$11.5M | $15.2M | $20.9M | $22.9M | $19.7M | $67.9M | $18.7M |
| Capital expenditure | $1.6M | $2.6M | $3.2M | $4.4M | $3.4M | $1.5M | $14.7M | $11.6M | $20.4M | $9.0M |
| Free cash flow | $16.8M | β$16.3M | $2.7M | β$15.9M | $11.8M | $19.4M | $8.2M | $8.2M | $47.4M | $9.7M |
| Depreciation and amortization | $2.2M | $2.0M | $2.3M | $2.6M | $3.1M | $3.1M | $3.6M | $7.6M | $9.5M | $9.8M |
| Stock-based compensation | $1.4M | $1.4M | $1.3M | $1.3M | $1.1M | $2.4M | $3.1M | $2.7M | $2.5M | $2.6M |
| Share buybacks | $4.8M | $1.1M | $7.7M | $7.5M | $2.0M | $0.0M | β | $0.4M | β | $1.1M |
| Dividends paid | $0.7M | $0.7M | $0.7M | $0.6M | $0.6M | $3.4M | $3.4M | $3.5M | $0.6M | $0.6M |
| Dividends and buybacks | $5.5M | $1.8M | $8.4M | $8.1M | $2.6M | $3.4M | $3.4M | $3.9M | $0.6M | $1.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.6M | $0.5M | $0.5M | $0.3M | $0.7M | $0.5M | $0.4M | $0.8M | $0.7M | $0.7M |
| Total debt | $3.4M | $3.0M | $4.8M | $3.7M | $3.1M | $5.6M | $9.0M | $13.6M | $21.8M | $16.5M |
| Current assets | $87.8M | $108M | $116M | $135M | $136M | $137M | $211M | $246M | $229M | $240M |
| Current liabilities | $28.9M | $29.6M | $34.4M | $31.6M | $41.9M | $47.1M | $72.0M | $76.6M | $93.2M | $112M |
| Inventory | $48.4M | $72.9M | $78.9M | $102M | $99.0M | $95.2M | $135M | $159M | $144M | $153M |
| Property and equipment, net | $12.6M | $13.3M | $15.8M | $17.7M | $17.5M | $16.0M | $48.1M | $80.6M | $106M | $108M |
| Goodwill | $6.3M | $6.3M | $4.4M | $4.4M | $4.4M | $4.4M | $5.3M | $5.8M | $5.8M | $5.8M |
| Intangible assets | $3.8M | $3.5M | $3.4M | $0.5M | $0.5M | $0.5M | $2.1M | $5.3M | $4.7M | $4.2M |
| Total assets | $111M | $132M | $140M | $158M | $188M | $188M | $289M | $363M | $374M | $391M |
| Total liabilities | $45.1M | $63.6M | $75.4M | $97.0M | $123M | $111M | $196M | $259M | $262M | $278M |
| Shareholders' equity | $65.8M | $68.2M | $64.6M | $60.8M | $64.8M | $77.6M | $92.8M | $104M | $112M | $113M |
| Margins | ||||||||||
| Gross margin | 5.8% | 5.7% | 5.8% | 6.0% | 5.8% | 6.0% | 6.4% | 6.7% | 6.7% | 6.7% |
| Operating margin | 0.8% | 0.5% | 0.4% | 0.5% | 0.6% | 1.1% | 1.1% | 1.0% | 0.7% | 0.4% |
| EBITDA margin | 1.0% | 0.6% | 0.6% | 0.6% | 0.8% | 1.3% | 1.3% | 1.3% | 1.0% | 0.8% |
| Net margin | 0.5% | 0.2% | 0.3% | 0.2% | 0.4% | 0.9% | 0.8% | 0.5% | 0.2% | 0.0% |
| FCF margin | 1.3% | β1.3% | 0.2% | β1.1% | 0.8% | 1.2% | 0.4% | 0.3% | 1.8% | 0.3% |
| Returns | ||||||||||
| Return on capital | 10.3% | 5.7% | 6.5% | 6.6% | 9.6% | 15.7% | 15.6% | 14.9% | 8.8% | 6.3% |
| Return on capital employed | 13.3% | 6.1% | 5.6% | 5.0% | 6.2% | 12.6% | 10.4% | 9.1% | 6.4% | 4.5% |
| Return on equity | 9.1% | 4.4% | 5.4% | 5.1% | 8.8% | 21.8% | 19.6% | 11.8% | 4.0% | 0.5% |
| Return on assets | 5.4% | 2.4% | 2.7% | 2.2% | 3.2% | 8.3% | 7.0% | 3.6% | 1.2% | 0.1% |
| Return on tangible equity | 10.5% | 5.1% | 6.4% | 5.7% | 9.3% | 21.4% | 19.5% | 12.5% | 4.3% | 0.6% |
| Growth | ||||||||||
| Revenue growth | β | β1.5% | 3.7% | 5.3% | 9.3% | 9.9% | 20.2% | 26.3% | 6.7% | 3.9% |
| Net income growth | β | β50.7% | 22.5% | β11.4% | 73.0% | 180.5% | 7.2% | β30.4% | β62.6% | β86.9% |
| EPS growth | β | β49.2% | 26.3% | β2.4% | 85.9% | 180.3% | 4.5% | β31.9% | β63.3% | β87.1% |
| FCF growth | β | β197.2% | β | β695.3% | β | 63.8% | β57.8% | β0.5% | 481.3% | β79.6% |
| Share count change | β | β3.0% | β2.9% | β9.3% | β6.9% | 0.0% | 2.6% | 2.2% | 1.8% | 1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.2x | 0.3x | 0.5x | 0.4x | 0.2x | 0.2x | 0.3x | 0.4x | 0.8x | 0.7x |
| Debt / equity | 0.1x | 0.0x | 0.1x | 0.1x | 0.0x | 0.1x | 0.1x | 0.1x | 0.2x | 0.1x |
| Interest coverage | 15.0x | 7.5x | 5.0x | 4.0x | 5.4x | 13.3x | 10.0x | 3.0x | 1.7x | 1.2x |
| Current ratio | 3.0x | 3.7x | 3.4x | 4.3x | 3.2x | 2.9x | 2.9x | 3.2x | 2.5x | 2.1x |
| Quick ratio | 1.4x | 1.2x | 1.1x | 1.0x | 0.9x | 0.9x | 1.1x | 1.1x | 0.9x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.1% | 0.2% | 0.2% | 0.3% | 0.2% | 0.1% | 0.7% | 0.5% | 0.8% | 0.3% |
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% |
| Payouts / FCF | 32.5% | β | 315.7% | β | 22.2% | 17.3% | 42.0% | 48.3% | 1.3% | 18.4% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 5.0 | 6.0 | 6.0 | 5.0 | 6.0 | 5.0 | 4.0 |
| Altman Z'' | 7.4 | 6.9 | 6.5 | 6.6 | 5.4 | 5.9 | 5.3 | 4.9 | 4.1 | 3.7 |
| Accruals ratio | β11.2% | 13.8% | β1.7% | 9.8% | β5.6% | β2.9% | β2.6% | β2.5% | β17.2% | β4.7% |
Source: SEC EDGAR XBRL filings (CIK 0000928465). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.